Should prophylaxis for Pneumocystis jirovecii pneumonia be considered in patients with a CD4+ count higher than 200 cells/μl?
Nitzan, Orna, Peretz, Avi, Pastukh, Nina, Lorber, MargalitVolume:
29
Language:
english
Journal:
AIDS
DOI:
10.1097/qad.0000000000000881
Date:
November, 2015
File:
PDF, 349 KB
english, 2015